Molecular and cellular analysis of human histamine receptor subtypes

Trends in Pharmacological Sciences

Volumn 34, Issue 1, 2013, Pages 33-58

  Seifert, Roland ^a   Strasser, Andrea ^b   Schneider, Erich H ^a   Neumann, Detlef ^a   Dove, Stefan ^b   Buschauer, Armin ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMTHAMINE; ARPROMIDINE; BETAHISTINE; CLOZAPINE; DIMAPRIT; FAMOTIDINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; HISTAMINERGIC RECEPTOR AFFECTING AGENT; HISTAPRODIFEN; IMETIT; IMPROMIDINE; INTERLEUKIN 2; LIGAND; LOXAPINE; MEPYRAMINE; PITOLISANT; PROTON PUMP INHIBITOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; THIOPERAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ASTHMA; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; INSECT CELL; NARCOLEPSY; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; REVIEW; SPECIES DIFFERENCE;

ANIMALS; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; HUMANS; MOLECULAR TARGETED THERAPY; RECEPTORS, HISTAMINE;

EID: 84871743467     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.11.001     Document Type: Review

References (217)

1. 1 antihistamines J. Investig. Allergol. Clin. Immunol. 19 Suppl. 1 2009 11 18
2. J.P. Ortonne Urticaria and its subtypes: the role of the second-generation antihistamines Eur. J. Intern. Med. 23 2012 26 30
3. + cells J. Immunol. 176 2006 7062 7070
4. 4-receptor Mol. Pharmacol. 76 2009 1019 1030
5. M.W. Greaves Antihistamines in dermatology Skin Pharmacol. Physiol. 18 2005 220 229
6. 2LEN position paper Allergy 65 2010 459 466
7. 4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus J. Allergy Clin. Immunol. 119 2007 176 183
8. 3 receptor: from discovery to clinical trials with pitolisant Br. J. Pharmacol. 163 2011 713 721
9. C.P. Page The scientific legacy of Sir James W. Black Trends Pharmacol. Sci. 32 2011 181 182
10. T. Hershcovici, and R. Fass Pharmacological management of GERD: where does it stand now? Trends Pharmacol. Sci. 32 2011 258 264
11. 2-receptors Naunyn Schmiedebergs Arch. Pharmacol. 340 1989 671 678
12. 2-receptors involved in the regulation of NADPH oxidase? Naunyn Schmiedebergs Arch. Pharmacol. 341 1990 455 461
13. 2 receptors expressed by leukemic cells Haematologica 97 2012 1904 1908
14. L.P. Yang, and C.M. Perry Histamine dihydrochloride in the management of acute myeloid leukaemia Drugs 71 2011 109 122
15. 2-receptor agonists in congestive heart failure Eur. J. Clin. Invest. 25 Suppl. 1 1995 42 46
16. M.E. Parsons, and C.R. Ganellin Histamine and its receptors Br. J. Pharmacol. 147 2006 S127 S135
17. H.L. Haas Histamine in the nervous system Physiol. Rev. 88 2008 1183 1241
18. 4 receptors in allergic inflammation: the search for new antihistamines Nat. Rev. Drug Discov. 7 2008 41 53
19. 4 receptor agonists Bioorg. Med. Chem. Lett. 20 2010 7191 7199
20. R. Leurs En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family Trends Pharmacol. Sci. 32 2011 250 257
21. 4 receptor in inflammatory skin diseases and pruritus Front. Biosci. (Schol. Ed.) 3 2011 985 994
22. 4 receptor ligands and their potential therapeutic applications: an update Expert Opin. Ther. Pat. 22 2012 205 221
23. Strasser, A. et al. (2013). Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. Trends Pharmacol. Sci., http://dx.doi.org/10.1016/j.tips.2012.10.004 (in press)
24. M. Jutel Histamine, histamine receptors and their role in immune pathology Clin. Exp. Allergy 39 2009 1786 1800
25. 1 receptors and is an incomplete secretagogue Mol. Pharmacol. 42 1992 227 234
26. 2+ mobilization from intracellular stores Naunyn Schmiedebergs Arch. Pharmacol. 349 1994 355 361
27. i proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes Mol. Pharmacol. 45 1994 578 586
28. 1-receptor J. Pharmacol. Exp. Ther. 305 2003 1104 1115
29. J. McDonald Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone-inducible mammalian expression system Br. J. Pharmacol. 140 2003 61 70
30. S. Galandrin The evasive nature of drug efficacy: implications for drug discovery Trends Pharmacol. Sci. 28 2007 423 430
31. T.P. Kenakin Biased signalling and allosteric machines: new vistas and challenges for drug discovery Br. J. Pharmacol. 165 2012 1659 1669
32. 2-receptor in human eosinophils and neutrophils Biochem. Pharmacol. 84 2012 1174 1185
33. 4-receptor: evidence for ligand-specific receptor conformations Biochem. Pharmacol. 84 2012 192 203
34. C. Gespach, and J.P. Abita Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP Mol. Pharmacol. 21 1982 78 85
35. C. Gespach Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils Mol. Pharmacol. 22 1982 547 553
36. 2 receptors with an unique agonist/antagonist profile and induces functional differentiation Mol. Pharmacol. 42 1992 235 241
37. 2 receptor activity during differentiation of the human monocytic-like cell line U-937. Comparison with prostaglandins and isoproterenol FEBS Lett. 184 1985 207 213
38. 2 histamine receptor signaling Mol. Pharmacol. 70 2006 493 500
39. 2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model Mol. Pharmacol. 64 2003 512 520
40. 2 receptors in the U937 cell line Biochem. Pharmacol. 60 2000 159 166
41. 2 receptor in the human promonocytic cell line U937 Mol. Pharmacol. 51 1997 983 990
42. S. Copsel Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation J. Biol. Chem. 286 2011 6979 6988
43. 3 receptor drugs Nat. Rev. Drug Discov. 4 2005 107 120
44. 3 receptor antagonists go to clinics Biol. Pharm. Bull. 31 2008 2163 2181
45. 4 receptor on human eosinophils-role in eosinophil chemotaxis J. Recept. Signal Transduct. Res. 22 2002 431 448
46. D.G. Raible Pharmacologic characterization of a novel histamine receptor on human eosinophils Am. J. Respir. Crit. Care Med. 149 1994 1506 1511
47. 4 receptor Br. J. Pharmacol. 140 2003 1117 1127
48. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation Br. J. Pharmacol. 142 2004 161 171
49. 3 receptors J. Invest. Dermatol. 123 2004 116 123
50. 4 receptor agonists J. Med. Chem. 52 2009 6297 6313
51. 4 receptor J. Allergy Clin. Immunol. 120 2007 300 307
52. 4-receptor lack specificity Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 125 135
53. R. Gutzmer Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 853 854
54. 4 receptor Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 855 860
55. 4 receptor agonist J. Pharmacol. Exp. Ther. 314 2005 1310 1321
56. 4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity Mol. Pharmacol. 79 2011 631 638
57. 1 receptor Biochem. Biophys. Res. Commun. 197 1993 1601 1608
58. 2 receptor stably expressed in Chinese hamster ovary cells Br. J. Pharmacol. 112 1994 847 854
59. K.L. Morse Cloning and characterization of a novel human histamine receptor J. Pharmacol. Exp. Ther. 296 2001 1058 1066
60. 1 receptor agonists J. Pharmacol. Exp. Ther. 322 2007 172 179
61. 2 receptor by G protein-coupled receptor kinase 2 J. Biol. Chem. 286 2011 28697 28706
62. 4 receptor antagonist with anti-inflammatory properties J. Pharmacol. Exp. Ther. 309 2004 404 413
63. q/11-subunits in constitutive and agonist-mediated signaling Mol. Pharmacol. 60 2001 1133 1142
64. 1-receptor species isoforms J. Pharmacol. Exp. Ther. 324 2008 60 71
65. 4-receptor Biochemistry 48 2009 1424 1438
66. o protein heterotrimers J. Pharmacol. Exp. Ther. 332 2010 996 1005
67. R. Seifert, and K. Wenzel-Seifert Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors Naunyn Schmiedebergs Arch. Pharmacol. 366 2002 381 416
68. sα fusion protein Eur. J. Biochem. 255 1998 369 382
69. 3 receptor Mol. Pharmacol. 55 1999 1101 1107
70. T. Oda Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes J. Biol. Chem. 275 2000 36781 36786
71. 4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins Mol. Pharmacol. 79 2011 749 757
72. S. Rajagopal Teaching old receptors new tricks: biasing seven-transmembrane receptors Nat. Rev. Drug Discov. 9 2010 373 386
73. q-protein coupling J. Neurochem. 80 2002 678 696
74. 2-receptor with guanidine-type agonists Mol. Pharmacol. 60 2001 1210 1215
75. sα J. Pharmacol. Exp. Ther. 299 2001 1013 1020
76. 4 receptor ligands Biochem. Pharmacol. 78 2009 607 616
77. A. Buschauer Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs J. Med. Chem. 32 1989 1963 1970
78. 2 receptor agonists J. Med. Chem. 51 2008 7193 7204
79. G-acylated imidazolylpropylguanidines J. Pharmacol. Exp. Ther. 317 2006 139 146
80. 2-receptors J. Pharmacol. Exp. Ther. 317 2006 1262 1268
81. G-substituent J. Med. Chem. 52 2009 2623 2627
82. 1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues J. Med. Chem. 38 1995 1287 1294
83. 1-receptor agonists J. Med. Chem. 43 2000 1071 1084
84. 4R-a pharmacological and molecular modelling study Naunyn Schmiedebergs Arch. Pharmacol. 384 2011 287 299
85. L.B. Hough Genomics meets histamine receptors: new subtypes, new receptors Mol. Pharmacol. 59 2001 415 419
86. 2-receptors Nature 236 1972 385 390
87. H2 cells J. Allergy Clin. Immunol. 123 2009 619 625
88. E. Fakra, and J.M. Azorin Clozapine for the treatment of schizophrenia Expert Opin. Pharmacother. 13 2012 1923 1935
89. 4R receptors with 34 antidepressants and antipsychotics Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 145 170
90. G.P. Reynolds, and S.L. Kirk Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms Pharmacol. Ther. 125 2010 169 179
91. P.M. Nooijen Haematological toxicity of clozapine and some other drugs used in psychiatry Hum. Psychopharmacol. 26 2011 112 119
92. 4R species variants Mol. Pharmacol. 77 2010 734 743
93. 2 receptor. I. Theoretical investigations of histamine binding to an oligopeptide mimicking a part of the fifth transmembrane α-helix J. Comput. Aided Mol. Des. 10 1996 461 478
94. 4 receptor-an explicit membrane molecular dynamics simulation study J. Chem. Inf. Model. 48 2008 1199 1210
95. R.R. Neubig International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification: XXXVIII. Update on terms and symbols in quantitative pharmacology Pharmacol. Rev. 55 2003 597 606
96. 4 receptor ligands J. Pharmacol. Exp. Ther. 334 2010 513 521
97. i and β-arrestin2 biased ligands Mol. Pharmacol. 82 2012 1174 1182
98. 3 receptor function by monovalent ions Neurosci. Lett. 472 2010 114 118
99. W. Liu Structural basis for allosteric regulation of GPCRs by sodium ions Science 337 2012 232 236
100. T. Kuroki Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis Prog. Brain Res. 172 2008 199 212
101. J.A. Lieberman Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection Pharmacol. Rev. 60 2008 358 403
102. 1A receptor properties Psychopharmacology (Berl.) 216 2011 451 473
103. 1 receptors J. Cell Biol. 110 1990 1211 1215
104. 1-histamine receptor antagonists in fluorescent imaging plate reader-based calcium assays J. Biomol. Screen. 4 1999 249 258
105. S.H. Diks Activation of the canonical β-catenin pathway by histamine J. Biol. Chem. 278 2003 52491 52496
106. 1 receptor itself through activation of receptor gene transcription J. Pharmacol. Sci. 103 2007 374 382
107. 1 receptor gene expression in HeLa cells J. Biol. Chem. 286 2011 30542 30551
108. 1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways Br. J. Pharmacol. 107 1992 448 455
109. 1 receptors in human U373 MG astrocytoma cells J. Neurochem. 71 1998 2626 2633
110. 2+-dependent inhibition of cyclic AMP accumulation by histamine and thapsigargin in human U373 MG astrocytoma cells Br. J. Pharmacol. 130 2000 1021 1030
111. J.A. Aria-Montaño Calcium-dependence of histamine- and carbachol-induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices Br. J. Pharmacol. 111 1994 598 608
112. 1-receptor antagonists based on receptor internalization J. Pharmacol. Sci. 107 2008 66 79
113. 1-receptors is predominantly regulated by their internalization in human astrocytoma cells J. Pharmacol. Sci. 119 2012 233 242
114. 1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells J. Neurooncol. 55 2001 81 89
115. 1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells Immunology 132 2011 578 588
116. 1 receptor in airway epithelial cells Acta Otolaryngol. 132 Suppl. 1 2012 S37 S43
117. 1 receptor expression in oral squamous cell carcinoma Clin. Oral Investig. 2012 10.1007/s00784-012- 0784-3
118. Y. Nagai Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells Immunology 136 2012 103 114
119. 1 receptor J. Allergy Clin. Immunol. 119 2007 472 481
120. 2+ mobilization pathway in human HL-60 promyelocytic leukemia cells J. Biol. Chem. 264 1989 18356 18362
121. 2+ influx in all-trans-retinoic acid-differentiated HL-60 cells independently of phospholipase C or adenylyl cyclase Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 123 129
122. 2 receptor desensitization in HL-60 human promyelocytic leukemia cells J. Pharmacol. Exp. Ther. 231 1984 1 7
123. M. Idzko Expression and function of histamine receptors in human monocyte-derived dendritic cells J. Allergy Clin. Immunol. 109 2002 839 846
124. K. Botturi Histamine induces Th2 activation through the histamine receptor 1 in house dust mite rhinitic but not asthmatic patients Clin. Exp. Allergy 40 2010 755 762
125. K. Nemeth Characterization and function of histamine receptors in human bone marrow stromal cells Stem Cells 30 2012 222 231
126. 2R) are associated with complicated courses of sigmoid diverticulitis J. Gastrointest. Surg. 16 2012 173 182
127. B.E. Seligmann Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes J. Immunol. 130 1983 1902 1909
128. 2 histamine response of granulocytes of asthmatic patients J. Clin. Invest. 59 1977 1080 1087
129. 2 histamine receptor response Science 194 1976 737 738
130. 2 receptors in peripheral blood monocytes J. Biol. Chem. 269 1994 9952 9956
131. 2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist J. Clin. Invest. 92 1993 281 287
132. H. Kohka Histamine is a potent inducer of IL-18 and IFN-γ in human peripheral blood mononuclear cells J. Immunol. 164 2000 6640 6646
133. 2 receptors in the human gastric cancer cell line HGT-1 Biochem. Biophys. Res. Commun. 116 1983 251 257
134. P. McKenna Protein kinase C inhibits cyclic adenosine monophosphate generation by histamine and truncated glucagon like peptide 1 in the human gastric cancer cell line HGT-1 Gut 34 1993 953 957
135. 2 receptor antagonists in the human gastric cancer cell line HGT-1. Structure-activity relationship of isocytosine-furan and imidazole derivatives related to cimetidine Biochem. Pharmacol. 35 1986 1825 1834
136. 2 receptor-mediated adenylate cyclase activation in the human gastric cancer cell line HGT-1 FEBS Lett. 177 1984 227 230
137. 2-receptors Cancer Res. 42 1982 1541 1548
138. 2 and histamine activate human eosinophils J. Immunol. 148 1992 3536 3542
139. 4 receptor J. Receptor Ligand Channel Res. 3 2010 37 49
140. 2 receptors mediate the inhibitory effect of histamine on human eosinophil degranulation Br. J. Pharmacol. 131 2000 482 488
141. 2+ entry in Th2 response induced by histamine in human monocyte-derived dendritic cells Int. Immunopharmacol. 12 2012 358 367
142. + T cells J. Pharmacol. Exp. Ther. 303 2002 300 307
143. 4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells J. Immunol. 174 2005 5224 5232
144. 4 histamine receptor in human natural killer cells, monocytes, and dendritic cells J. Immunol. 179 2007 7907 7915
145. 4 receptor Am. J. Pathol. 180 2012 177 185
146. 4 in colorectal carcinomas: a potential influence on tumor growth and progression BMC Cancer 11 2011 195
147. 4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells PLoS ONE 4 2009 e6504
148. 4 agonism in antigen-specific human T-cell responses Immunology 121 2007 266 275
149. 3-adrenoceptors Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 875 882
150. G. Jositsch Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 389 395
151. W. Pradidarcheep Lack of specificity of commercially available antisera against muscarinic and adrenergic receptors Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 397 402
152. M.C. Michel How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 385 388
153. 1-receptor antagonists in HL-60 cells, basophils, and mast cells Biochem. Pharmacol. 51 1996 125 131
154. A. Hagelüken Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60) and human erythroleukemia (HEL) cells Biochem. Pharmacol. 49 1995 901 914
155. A. Hagelüken Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidied derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism Naunyn Schmiedebergs Arch. Pharmacol. 351 1995 305 308
156. 2-agonist activity in monocytes Mol. Pharmacol. 70 2006 450 453
157. D.R. Davies, and G.H. Cohen Interactions of protein antigens with antibodies Proc. Natl. Acad. Sci. U.S.A. 93 1996 7 12
158. M.H.V. Van Regenmortel Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity Methods 9 1996 465 472
159. R. Rapberger Identification of discontinuous antigenic determinants on proteins based on shape complementarities J. Mol. Recognit. 20 2007 113 121
160. N.H. Trier Production and characterization of peptide antibodies Methods 56 2012 136 144
161. N. Hamdani, and J. van der Velden Lack of specificity of antibodies directed against human β-adrenergic receptors Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 403 407
162. 1-adrenergic receptor subtypes are nonspecific Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 409 412
163. S. Bodei Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedebergs Arch. Pharmacol. 379 2009 413 415
164. B.K. Kobilka, and X. Deupi Conformational complexity of G-protein-coupled receptors Trends Pharmacol. Sci. 28 2007 397 406
165. B. Allard Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor DNA Cell Biol. 30 2011 727 737
166. M.M. Harmsen, and H.J. De Haard Properties, production, and applications of camelid single-domain antibody fragments Appl. Microbiol. Biotechnol. 77 2007 13 22
167. 2 receptors Nature 276 1978 403 405
168. 4 receptor radioligand ChemMedChem 4 2009 225 231
169. 2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles J. Med. Chem. 35 1992 3239 3246
170. 2 receptor agonists ChemMedChem 4 2009 232 240
171. 2 receptor agonists J. Med. Chem. 55 2012 1147 1160
172. 3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships Arch. Pharm. (Weinheim) 329 1996 379 385
173. 3 receptors in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 100 2003 11086 11091
174. 4 receptor agonist J. Med. Chem. 49 2006 6650 6651
175. 4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives J. Med. Chem. 49 2006 4512 4516
176. 4 receptor inverse agonists using a scaffold hopping approach J. Med. Chem. 51 2008 7855 7865
177. 4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia J. Med. Chem. 51 2008 7094 7098
178. 2 receptors J. Pharmacol. Exp. Ther. 321 2007 983 995
179. 2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity J. Pharmacol. Exp. Ther. 321 2007 975 982
180. 4 receptor J. Pharmacol. Exp. Ther. 333 2010 382 392
181. 1-receptor J. Pharmacol. Exp. Ther. 326 2008 783 791
182. 1R Biochem. Pharmacol. 82 2011 1910 1918
183. 4 receptor in receptor activation Naunyn Schmiedebergs Arch. Pharmacol. 384 2011 301 317
184. sα has properties of a constitutively active receptor J. Biol. Chem. 273 1998 5109 5116
185. C. Harteneck The Drosophila cation channel trpl expressed in insect Sf9 cells is stimulated by agonists of G-protein-coupled receptors FEBS Lett. 358 1995 297 300
186. 2 histamine receptor to phospholipase C Mol. Endocrinol. 10 1996 1697 1707
187. D. Leopoldt G proteins endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 216 224
188. 3-receptors Biochem. Pharmacol. 80 2010 1437 1449
189. 1-histamine- receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene Eur. J. Biochem. 224 1994 489 495
190. 3H]-tiotidine binding Br. J. Pharmacol. 103 1991 1573 1579
191. 2 receptor Biochem. Biophys. Res. Commun. 178 1991 1386 1392
192. 2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment Biochem. Biophys. Res. Commun. 176 1991 1027 1032
193. 3 receptors: role of two amino acids in the third transmembrane domain Br. J. Pharmacol. 131 2000 1247 1250
194. 4 receptors: structure-activity relationships of histamine derivatives Br. J. Pharmacol. 147 2006 744 754
195. 2 receptors Arch. Pharm. (Weinheim) 340 2007 9 16
196. 2 receptor do not affect the species-selective activity of guanidine-type agonists Naunyn Schmiedebergs Arch. Pharmacol. 376 2007 253 264
197. 2R J. Pharm. Pharmacol. 63 2011 1043 1055
198. E.H. Schneider, and R. Seifert Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors Pharmacol. Ther. 128 2010 387 418
199. E.H. Schneider, and R. Seifert Fusion proteins as model systems for the analysis of constitutive GPCR activity Methods Enzymol. 485 2010 459 480
200. E.H. Schneider, and R. Seifert Coexpression systems as models for the analysis of constitutive GPCR activity Methods Enzymol. 485 2010 527 557
201. 1-receptor Mol. Pharmacol. 75 2009 454 465
202. 1-receptor Mol. Pharmacol. 76 2009 25 37
203. 4R Bioorg. Med. Chem. Lett. 21 2011 6274 6280
204. J.A. Ballesteros, and H. Weinstein Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains Biophys. J. 62 1992 107 109
205. 1 receptor J. Biol. Chem. 274 1999 29994 30000
206. 1 agonists Biochem. Biophys. Res. Commun. 214 1995 110 117
207. 1-receptor agonists Biochem. Biophys. Res. Commun. 201 1994 295 301
208. 1 receptor: roles of aspartic acid107, asparagine198 and threonine194 Biochem. Biophys. Res. Commun. 203 1994 1096 1101
209. 2 receptor J. Biol. Chem. 267 1992 20840 20843
210. 3 receptor J. Pharmacol. Exp. Ther. 301 2002 451 458
211. 4 receptor Mol. Pharmacol. 62 2002 38 47
212. 4 receptors J. Pharmacol. Exp. Ther. 327 2008 88 96
213. 1 receptor complex with doxepin Nature 475 2011 65 70
214. 2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
215. 2 adrenoceptor Nature 469 2011 175 180
216. J. Wang Development and testing of a general amber force field J. Comput. Chem. 25 2004 1157 1174
217. M. Clark Validation of the general purpose tripos 5.2 force field J. Comput. Chem. 10 1989 982 1012